We will start our first talc trial in St. Louis this month. The trial involving Johnson & Johnson and Luzenac America was scheduled to commence on Feb. 1 and at press time it was still on. This case involves J&J’s talcum powder products, the companies knowledge of the risk of ovarian cancer and the failure by J&J to warn users of the risk. To this day, both J&J and Luzenac America has never warned women who use the products about the cancer risk. Luzenac did issue a warning, however, it went to J&J. The trial is expected to last for about three weeks. We currently represent 6,200 individuals in this litigation, and this trial is important – not just to all clients – but also to thousands of victims and their families.
Contact us today for a free legal consultation with an experienced attorney.
Fields marked *may be required for submission.
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.